Linus Pauling Institute Oregon State University Updated in January 2014 by: Barbara Delage, Ph.D
Our Research Peptide Catalog BPC-157 - Body Protection Compound, 5mg/10mg vials, 99% purity TB-500 - Thymosin Beta-4 Fragment, 5mg/10mg vials, 99% purity Epithalon - Epitalon tetrapeptide, 10mg/50mg vials, 99% purity GHK-Cu - Copper peptide, 50mg/200mg vials, 99% purity MOTS-C - Mitochondrial peptide, 5mg/10mg vials, 99% purity Ipamorelin - Growth hormone secretagogue, 5mg vials, 99% purity CJC-1295 (no DAC) - GHRH analog, 5mg vials, 99% purity NAD+ - Nicotinamide adenine dinucleotide, 500mg/1000mg vials SLU-PP-332 - Research compound, 50mg vials, 99% purity Nova Triple G - Research peptide blend, 12mg vials Bacteriostatic Water - Sterile reconstitution solution, 10ml vials Quality Standards All NovaCell research peptides undergo rigorous quality control: HPLC Analysis - High-Performance Liquid Chromatography for purity verification LC-MS Testing - Mass spectrometry for molecular identity confirmation COA Documentation - Certificate of Analysis for every batch Lot Tracking - Full traceability from synthesis to delivery EU Shipping Discreet shipping throughout the European Union
The study was small and had no comparison group, but the fact that relief lasted many months is noteworthy
However, if your body has trouble absorbing nutrients (which is common after certain GI conditions or surgeries), your provider may recommend B12 injections
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
.png)
